Issue of Equity and Total Voting Rights

AI SummaryClose X

SkinBioTherapeutics plc has announced the issuance of 259,472 new ordinary shares, valued at 1 pence each, pursuant to a share option agreement with a former employee. These new shares will be admitted to trading on the AIM Market of the London Stock Exchange on 13 February 2026, at which point the company's total voting rights will increase to 259,168,671 ordinary shares. This figure will serve as the denominator for shareholders calculating their notification obligations under the FCA's Disclosure Guidance and Transparency Rules.

Disclaimer*

UK 100

Latest directors dealings